Ignite Creation Date:
2025-12-25 @ 2:04 AM
Ignite Modification Date:
2025-12-27 @ 11:18 PM
Study NCT ID:
NCT05287360
Status:
COMPLETED
Last Update Posted:
2022-04-18
First Post:
2022-03-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study Comparing Four Different Rivoceranib Tablets in Healthy Participants
Sponsor:
Elevar Therapeutics
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-12-30
Start Date Type:
ACTUAL
Primary Completion Date:
2022-03-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-03-24
Completion Date Type:
ACTUAL
First Submit Date:
2022-03-10
First Submit QC Date:
None
Study First Post Date:
2022-03-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-04-15
Last Update Post Date:
2022-04-18
Last Update Post Date Type:
ACTUAL